Ethacrynic Acid Tablet
Product Images NDC 50228-334
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Ethacrynic Acid (NDC 50228-334). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sciegen Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Principal Display Panel (30 Tablet Bottle Label)
Each tablet of Ethacrynic Acid contains 25 mg of the drug. It is advised to refer to the prescribing information for the usual dosage. The tablets should be stored in a tightly closed container at a temperature of 25°C (77°F) with excursions permitted to 15° to 30°C (59° to S6°F). It is recommended to dispense them in two well-closed containers and kept out of the reach of children. The tablets are manufactured by ScieGen Pharmaceuticals, Inc., located in Hauppauge, NY 11788. The LOT and EXP numbers are not available. It is Rx-only and comes in a pack of 30 tablets.*
Principal Display Panel (100 Tablet Bottle Label)
This is a medication containing 25mg of Ethacrynic Acid USP. The tablets should be kept at a temperature range of 15°C to 30°C and dispensed in a closed container. The packaging contains 100 tablets and is not intended for dispensing. It is important to keep the medication away from children. Manufactured by SciaGen Pharmaceuticals Inc in New York.*
Principal Display Panel (1,000 Tablet Bottle Label)
Each tablet contains 25 mg of Ethacrynic acid, USP. This medication is intended for prescription use only, and the dosage information should be obtained from the accompanying prescribing information. The tablets should be stored in a tightly closed container at temperatures between 25°C and 30°C and dispensed in a well-closed container. This bulk package is not child-resistant and must be kept out of the reach of children. The medication comes in a package of 1000 tablets and was manufactured by ScieGen Pharmaceuticals, Inc., located in Hauppauge, NY. The Lot number and expiration date are indicated on the packaging.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.